Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00197678 · ClinicalTrials.gov registry record · Phase 3
Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women
A Phase 3 study, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- Phase 3
- Development phase
- 1,141
- Enrollment target
NCT00197678 is a Phase 3 study that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 1,141 participants.
The verdict
NCT00197678, a Phase 3 study, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,141 participants
- Enrollment target
Study Summary
The purpose of this study is to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV positive women decreases the risks of low birth weight (\<2500 g), and pre-term birth (\< 37 weeks gestation), compared to multivitamin supplements at doses above the RDA.
Interventions
- DIETARY_SUPPLEMENT Multivitamins-Multiples of RDA
- DIETARY_SUPPLEMENT Multivitamins-Single RDA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,141 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00197678
The ClinicalTrials.gov registry entry for NCT00197678 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Multivitamins-Multiples of RDA is the first listed.
NCT00197678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00197678 about?
NCT00197678 is a clinical study titled "Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women". The purpose of this study is to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV positive women decreases the risks of low birth weight (\<2500 g), and pre-term birth (\< 37 weeks gestation), compa...
What is the current status of trial NCT00197678?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,141 participants. The study started on 2002-11. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00197678?
The interventions under investigation include: Multivitamins-Multiples of RDA (DIETARY_SUPPLEMENT), Multivitamins-Single RDA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00197678?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.